Skip to main content

Table 2 Characteristics of include studies

From: Serum cystatin C is associated with the prognosis in acute myocardial infarction patients after coronary revascularization: a systematic review and meta-analysis

Author/year

Patients

Intervention

Outcome

Adjustment

Ichimoto/2009 [28]

STEMI

PCI

Cardiovascular events

Age; Killip class;

Time from hospital presentation to angioplasty;

Prior myocardial infarction; Creatinine;

Silva/2012 [7]

STEMI

PCI

Death/reinfarction

LVEF;

Sun/2012 [8]

AMI

PCI

Major adverse cardiac events

NA;

Akgul/2013 [9]

STEMI

PCI

Major adverse cardiac events

Age; gender; diabetes; hypertension; Killip class; anemia; renal failure; No-reflow; Three-vessel disease; unsuccessful procedure; LVEF;

Angeli/2015 [29]

non-ST-elevation ACS

PCI

All-cause mortality

Age; gender; diabetes; unsuccessful PCI; LVEF; Multivessel disease; Statin prescription at discharge; eGFR;

Lee/2015 [18]

ACS

CABG

Mortality and major adverse cerebrovascular and cardiovascular events

NA;

Dardashti/2016 [30]

CHD

CABG

All-cause mortality

Age; LVEF; logarithm of time in ICU; hemoglobin; plasma transfused; creatinine;

Shen/2018 [31]

STEMI

PCI

Major adverse cardiac events

Age; SBP ≥ 140 (mmHg); NT-proBNP; eGFR; LVEF;

  1. PCI percutaneous coronary intervention, CABG coronary artery bypass grafting, LVEF left ventricular ejection fraction, SBP systolic blood pressure, eGFR estimate glomerular filtration rate, ICU intensive care unit, m month, y year, NA not applicable, STEMI ST-elevation myocardial infarction, ACS acute coronary syndrome, CHD coronary heart disease